- Home
- PCSA vs FRGT Comparison
PCSA vs FRGT Comparison
Compare PCSA & FRGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCSA
- FRGT
- Stock Information
- Founded
- PCSA 2011
- FRGT 2015
- Country
- PCSA United States
- FRGT United States
- Employees
- PCSA N/A
- FRGT N/A
- Industry
- PCSA Biotechnology: Pharmaceutical Preparations
- FRGT Professional Services
- Sector
- PCSA Health Care
- FRGT Consumer Discretionary
- Exchange
- PCSA Nasdaq
- FRGT Nasdaq
- Market Cap
- PCSA 2.7M
- FRGT 2.8M
- IPO Year
- PCSA N/A
- FRGT N/A
- Fundamental
- Price
- PCSA $0.64
- FRGT $1.33
- Analyst Decision
- PCSA Strong Buy
- FRGT
- Analyst Count
- PCSA 2
- FRGT 0
- Target Price
- PCSA $5.00
- FRGT N/A
- AVG Volume (30 Days)
- PCSA 452.0K
- FRGT 166.1K
- Earning Date
- PCSA 03-28-2025
- FRGT 02-11-2025
- Dividend Yield
- PCSA N/A
- FRGT N/A
- EPS Growth
- PCSA N/A
- FRGT N/A
- EPS
- PCSA N/A
- FRGT N/A
- Revenue
- PCSA N/A
- FRGT $17,567,033.00
- Revenue This Year
- PCSA N/A
- FRGT $144.53
- Revenue Next Year
- PCSA N/A
- FRGT $55.01
- P/E Ratio
- PCSA N/A
- FRGT N/A
- Revenue Growth
- PCSA N/A
- FRGT N/A
- 52 Week Low
- PCSA $0.47
- FRGT $1.25
- 52 Week High
- PCSA $3.31
- FRGT $67.25
- Technical
- Relative Strength Index (RSI)
- PCSA 39.43
- FRGT 36.63
- Support Level
- PCSA $0.58
- FRGT $1.28
- Resistance Level
- PCSA $0.81
- FRGT $1.44
- Average True Range (ATR)
- PCSA 0.09
- FRGT 0.10
- MACD
- PCSA -0.00
- FRGT -0.02
- Stochastic Oscillator
- PCSA 47.96
- FRGT 5.43
About PCSA Processa Pharmaceuticals Inc.
Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its "regulatory science" approach in the development of Next Generation Chemotherapy ("NGC") oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small molecule oncology drugs. The NGC products are new chemical entities, but the company work by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are - NGC-Capecitabine (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).
About FRGT Freight Technologies Inc.
Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.